Platform Collaboration The self-adjuvanting mRNA vaccine platform and CEPI collaboration create licensing or co-development opportunities with vaccine developers and global health programs.

Outsourcing Partners With a small team, Celestial Therapeutics may benefit from contract research, regulatory support, and pilot-scale manufacturing partnerships to advance preclinical and early clinical programs.

Funding Catalyst Recent funding activity signals openness to strategic collaborations and co-investment; propose milestone-based deals with grant or venture funding to de-risk development.

Indication Focus Core focus on infectious diseases, inflammatory conditions, rare diseases, and cancers suggests targeting pharma partners seeking new platforms or collaborations in these indications for licensing or joint development.

Local Ecosystem Leverage the San Diego biotech cluster to connect with local CROs, academic partners, and clinical networks for faster preclinical work and translational programs.